HST
49
-9
CMA
61
5
MCD
52
2
PEP
48
6
NVDA
56
-4
PRGO
39
3
F
58
11
TDC
80
4
URBN
56
14
PPL
54
-5
PNC
64
4
CCI
31
3
CF
57
-2
DNB
82
4
SE
61
-4
NSC
60
3
WEC
53
-2
TRIP
47
3
BF.B
33
2
APD
59
2
HST
49
-9
CMA
61
5
MCD
52
2
PEP
48
6
NVDA
56
-4
PRGO
39
3
F
58
11
TDC
80
4
URBN
56
14
PPL
54
-5
PNC
64
4
CCI
31
3
CF
57
-2
DNB
82
4
SE
61
-4
NSC
60
3
WEC
53
-2
TRIP
47
3
BF.B
33
2
APD
59
2
Financhill
Back

Alterity Therapeutics 10K Form

Sell
23

ATHE
Alterity Therapeutics

Last Price:
1.08
Seasonality Move:
-3.88%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ATHE News And Ratings

See the #1 stock for the next 7 days that we like better than ATHE

ATHE Financial Statistics

Sales & Book Value

Annual Sales: $99.82K
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.78
Price / Book: 0

Profitability

EPS (TTM): -0.70920
Net Income (TTM): $-11.16M
Gross Margin: $189.63K
Return on Equity: 0%
Return on Assets: 0%

Alterity Therapeutics Earnings Forecast

Key Alterity Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 3 years for ATHE is 100.00%.
  • The Selling, General & Administrative Expenses for ATHE have been equal to 2,981.41% of Gross Profit Margin.
  • The Interest Expense is -0.22% of Operating Income.
  • Per Share Earnings over the last 27 years have been positive in 12 years.

Alterity Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ATHE
CUSIP: 02155X
Website: alteritytherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ATHE Technical Analysis vs Fundamental Analysis

Sell
23
Alterity Therapeutics (ATHE) is a Sell

Is Alterity Therapeutics a Buy or a Sell?